3Body JJ,Bartl R,Burckhardt P,et al.Current use of bisphosphonates in oncology.International Bone and Cancer Study Group[J].J Clin Oncol,1998,16:3890-3899.
4Body JJ.Hypercalcemia of malignancy[J].Semin Nephrol,2004,24:48-54.
5Major P,Lortholary A,Hon J,et al.Zoledronate acid is superior to pamidronate in the treatment of hypercalcemia of malignancy:A pooled analysis of two randomized,controlled clinical trials[J].J Clin Oncol,2001,19:558-567.
6Kawada K,Minami H,Okabe K,et al.A multicenter and open label clinical trial of zelodronic acid 4mg in patients with hypercalcemia of malignancy[J].Jpn J Clin Oncol,2005,35:28-33.
7Conte P,Coleman R.Bisphosphonates in the treatment of skeletal metastases[J].Semin Oncol,2004,31 (Suppl 10):59-63.
8Cameron D.Proven efficacy of zoledronate acid in the treatment of bone metastases in patients with breast cancer and other malignancies[J].Breast,2003,12(Supple 2):S22-29.
10Rosen LS,Gordon D,Kaminski M,et al.Zoledronic acid verse pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma:a phase Ⅲ,double-blind,comparative trial[J].Cancer J,2001,7:377-387.
